These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30634681)

  • 1. Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells.
    Pereira-Oliveira M; Reis-Mendes A; Carvalho F; Remião F; Bastos ML; Costa VM
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30634681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells.
    Reis-Mendes A; Carvalho F; Remião F; Sousa E; Bastos ML; Costa VM
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30862114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress.
    Lamberti M; Porto S; Marra M; Zappavigna S; Grimaldi A; Feola D; Pesce D; Naviglio S; Spina A; Sannolo N; Caraglia M
    J Exp Clin Cancer Res; 2012 Jul; 31(1):60. PubMed ID: 22812382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
    Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
    Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cell death caused by CDF (cyclophosphamide, doxorubicin, 5-fluorouracil) multi-drug administration in the human breast cancer cell line MCF-7.
    Kugawa F; Ueno A; Kawasaki M; Aoki M
    Biol Pharm Bull; 2004 Mar; 27(3):392-8. PubMed ID: 14993808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells.
    Reis-Mendes A; Alves M; Carvalho F; Remião F; Bastos ML; Costa VM
    Interdiscip Toxicol; 2018 May; 11(1):13-21. PubMed ID: 30181708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
    Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro.
    Wang WC; Uen YH; Chang ML; Cheah KP; Li JS; Yu WY; Lee KC; Choy CS; Hu CM
    BMC Complement Altern Med; 2012 Aug; 12():138. PubMed ID: 22920231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts.
    Branco AF; Sampaio SF; Moreira AC; Holy J; Wallace KB; Baldeiras I; Oliveira PJ; Sardão VA
    Cardiovasc Toxicol; 2012 Dec; 12(4):326-40. PubMed ID: 22744233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
    Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
    Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group.
    Martin M; Villar A; Sole-Calvo A; Gonzalez R; Massuti B; Lizon J; Camps C; Carrato A; Casado A; Candel MT; Albanell J; Aranda J; Munarriz B; Campbell J; Diaz-Rubio E;
    Ann Oncol; 2003 Jun; 14(6):833-42. PubMed ID: 12796019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
    Zhang Y; Ahmad KA; Khan FU; Yan S; Ihsan AU; Ding Q
    Chem Biol Interact; 2019 May; 305():54-65. PubMed ID: 30928397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27.
    Turakhia S; Venkatakrishnan CD; Dunsmore K; Wong H; Kuppusamy P; Zweier JL; Ilangovan G
    Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3111-21. PubMed ID: 17873025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.
    Sardão VA; Oliveira PJ; Holy J; Oliveira CR; Wallace KB
    Cell Biol Toxicol; 2009 Jun; 25(3):227-43. PubMed ID: 18386138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicity in vitro.
    Liu Z; Song XD; Xin Y; Wang XJ; Yu H; Bai YY; Liu JH; Zhang CN; Hui RT
    Chin Med J (Engl); 2009 Nov; 122(21):2652-6. PubMed ID: 19951587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
    Reis-Mendes A; Gomes AS; Carvalho RA; Carvalho F; Remião F; Pinto M; Bastos ML; Sousa E; Costa VM
    Arch Toxicol; 2017 Apr; 91(4):1871-1890. PubMed ID: 27629428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone.
    Damiani RM; Moura DJ; Viau CM; Brito V; Morás AM; Henriques JAP; Saffi J
    Toxicol In Vitro; 2018 Oct; 52():203-213. PubMed ID: 29913208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
    Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
    Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diethyl Blechnic, a Novel Natural Product Isolated from
    Yu J; Gao H; Wu C; Xu QM; Lu JJ; Chen X
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29921821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.